In vitro activity of glufosfamide in childhood acute leukemia

Anticancer Research

Volumn 22, Issue 1 A, 2002, Pages 247-250

  Styczynski, Jan ^a   Wysocki, Mariusz ^a   Kurylak, Andrzej ^a   Juraszewska, Edyta ^a   Malinowska, Iwona ^a   Stanczak, Elzbieta ^a   Płoszynska, Anna ^a   Stefaniak, Jolanta ^a   Mazur, Benigna ^a   Szczepanski, Tomasz ^a   Ras, Malgorzata ^a  

^a NONE   (Poland)

Author keywords

Glufosfamide; Leukemia; MTT assay; Oxazaphosphorines

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; 4 HYDROPEROXYIFOSFAMIDE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYTARABINE; DAUNORUBICIN; GLUFOSFAMIDE; MAFOSFAMIDE; OXAZAPHOSPHORINE DERIVATIVE; PREDNISOLONE SODIUM TETRAHYDROPHTHALATE; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IFOSFAMIDE; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; PHOSPHORAMIDE MUSTARDS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 0036254722     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Basis and new developments in the field of oxazaphosphorines
2. Short communication: Cause and prevention of mafosfamide-induced venous pain
3. Mafosfamide - A derivative of 4-hydroxycyclophosphamide
4. D-19575 - A sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport
5. Pharmacokinetics and whole-body distribution of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard and its effects on the incorporation of (methyl-3H)-thymidine in various tissues of the rat
6. Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT 1
7. Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent
8. In vitro drug resistance profiles in adult versus childhood acute lymphoblastic leukemia
9. Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: A study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group
10. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: Significance for ex vivo purging of bone marrow for autologous transplantation